(Q45736315)

English

Adenoviral gene transfer into dendritic cells efficiently amplifies the immune response to LMP2A antigen: a potential treatment strategy for Epstein-Barr virus--positive Hodgkin's lymphoma

scientific article published in September 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

15 December 2017

Adenoviral gene transfer into dendritic cells efficiently amplifies the immune response to LMP2A antigen: a potential treatment strategy for Epstein-Barr virus--positive Hodgkin's lymphoma (English)

1 reference

Europe PubMed Central

15 December 2017

Epstein–Barr virus

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Fernando Siller-López

2

1 reference

Europe PubMed Central

15 December 2017

Cliona M Rooney

10

object named as

C M Rooney

1 reference

Europe PubMed Central

15 December 2017

Malcolm Brenner

7

object named as

M K Brenner

1 reference

Europe PubMed Central

15 December 2017

8

object named as

H E Heslop

1 reference

Europe PubMed Central

15 December 2017

author name string

B Gahn

1

1 reference

Europe PubMed Central

15 December 2017

A D Pirooz

3

1 reference

Europe PubMed Central

15 December 2017

E Yvon

4

1 reference

Europe PubMed Central

15 December 2017

S Gottschalk

5

1 reference

Europe PubMed Central

15 December 2017

R Longnecker

6

1 reference

Europe PubMed Central

15 December 2017

E Aguilar-Cordova

9

1 reference

Europe PubMed Central

15 December 2017

language of work or name

0 references

publication date

1 September 2001

1 reference

Europe PubMed Central

15 December 2017

number of pages

8

1 reference

based on heuristic

inferred from page(s)

International Journal of Cancer

1 reference

Europe PubMed Central

15 December 2017

93

1 reference

Europe PubMed Central

15 December 2017

5

1 reference

Europe PubMed Central

15 December 2017

706-713

1 reference

Europe PubMed Central

15 December 2017

Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1396

21 January 2018

Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1396

21 January 2018

Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1396

21 January 2018

Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1396

21 January 2018

Epstein-Barr virus latent membrane protein expression in Hodgkin and Reed-Sternberg cells

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1396

21 January 2018

Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1396

21 January 2018

Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1396

21 January 2018

Epstein-Barr virus (EBV)-encoded membrane protein LMP1 from a nasopharyngeal carcinoma is non-immunogenic in a murine model system, in contrast to a B cell-derived homologue.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1396

21 January 2018

Sequence polymorphism in the Epstein-Barr virus latent membrane protein (LMP)-2 gene.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1396

21 January 2018

Dendritic cells generated from human blood in granulocyte macrophage-colony stimulating factor and interleukin-7.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1396

21 January 2018

Human PBMC-derived dendritic cells transduced with an adenovirus vectorinduce cytotoxic T-lymphocyte responses against a vector-encoded antigen in vitro.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1396

21 January 2018

Enrichment of an antigen-specific T cell response by retrovirally transduced human dendritic cells.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1396

21 January 2018

A simplified system for generating recombinant adenoviruses

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1396

21 January 2018

Sensitivity and reproducibility in adenoviral infectious titer determination

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1396

21 January 2018

Immune response to green fluorescent protein: implications for gene therapy

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1396

21 January 2018

Construction and characterization of a recombinant adenovirus directing expression of the MAGE-1 tumor-specific antigen

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1396

21 January 2018

Dendritic cells loaded with MART-1 peptide or infected with adenoviral construct are functionally equivalent in the induction of tumor-specific cytotoxic T lymphocyte responses in patients with melanoma

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1396

21 January 2018

Secondary leukaemia and myelodysplasia after autografting for lymphoma: results from the EBMT. EBMT Lymphoma and Late Effects Working Parties. European Group for Blood and Marrow Transplantation

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1396

21 January 2018

In vitro priming with adenovirus/gp100 antigen-transduced dendritic cells reveals the epitope specificity of HLA-A*0201-restricted CD8+ T cells in patients with melanoma

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1396

21 January 2018

Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1396

21 January 2018

Identifiers

10.1002/IJC.1396

1 reference

Europe PubMed Central

15 December 2017

1 reference

Europe PubMed Central

15 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45736315&oldid=2079102562"